Biogen, Inc. (BIIB)
201.18
+15.82
(+8.53%)
USD |
NASDAQ |
Feb 06, 16:00
197.28
-3.90
(-1.94%)
After-Hours: 20:00
Biogen EPS Diluted (Quarterly) : -0.3333 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.390 |
| Merck & Co., Inc. | 1.191 |
| AbbVie, Inc. | 1.024 |
| Stoke Therapeutics, Inc. | -0.6543 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -48.90M |
| Revenue (Quarterly) | 2.181B |
| Total Expenses (Quarterly) | 2.230B |
| Enterprise Value | 32.36B |
| Gross Profit Margin (Quarterly) | 68.10% |
| Profit Margin (Quarterly) | -2.24% |
| Earnings Yield | 4.38% |
| Operating Earnings Yield | 8.16% |
| Normalized Earnings Yield | 5.770 |